Contra-indicatie mammacarcinoom

Autor: Brood-van Zanten, MMA

Publikováno v: Brood-van Zanten, MMA 2022, Contra-indicatie mammacarcinoom . in Commentaren Medicatiebewaking .
Commentaren Medicatiebewaking

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5b4c3fff3a4bad11b06c23629750485e
https://research.vumc.nl/en/publications/810da7a4-b481-4924-af03-6c83b8f748d6

Postmenopauzale hormoonsuppletietherapie (on)veilig

Autor: Brood-van Zanten, MMA, Lok, CAR, Rookus, Matti A.

Publikováno v: Brood-van Zanten, MMA, Lok, CAR & Rookus, M A 2019, ' Postmenopauzale hormoonsuppletietherapie (on)veilig ', Geaccrediteerde nascholing farmacotherapie, vol. 9, no. 3, pp. 34-38 .
Geaccrediteerde nascholing farmacotherapie, 9(3), 34-38

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e9d0b13185fa1057546655882181b3cf
https://research.vumc.nl/en/publications/fa86b937-5437-4266-8a18-44d13539df77

Borstkanker en overgangsklachten

Autor: Brood-van Zanten, MMA, Franke, H., Kenemans, P, van der Mooren, M.J., Burger, C.W.

Publikováno v: Brood-van Zanten, MMA, Franke, H, Kenemans, P, van der Mooren, M J & Burger, C W 2006, ' Borstkanker en overgangsklachten ', Medisch Contact, vol. 61, no. 24, 24, pp. 987 .
Medisch Contact, 61(24):24

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::37aa889d9c92fe7dd7fa4bd3e9463e62
https://research.vumc.nl/en/publications/d8f224fc-a4a4-4db5-89f8-c9a2c78f1904

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.

Autor: Nebgen DR; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Domchek SM; Basser Center for BRCA, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kotsopoulos J; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada., de Hullu JA; Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, The Netherlands., Crosbie EJ; Division of Cancer Sciences, University of Manchester, St Mary's Hospital, Manchester, UK., Paramanandam VS; Department of Obstetrics and Gynaecology, The Royal Women's Hospital, The University of Melbourne, Melbourne, Victoria, Australia., Brood-van Zanten MMA; Department of Gynecology, The Netherlands Cancer Institute, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Norquist BM; Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA., Guise T; Department of Endocrine Neoplasia and Hormone Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rozenberg S; Department of Obstetrics and Gynaecology, Universite Libre de Bruxelles, Brussels, Belgium., Kurian AW; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA., Pederson HJ; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Yuksel N; Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada., Michaelson-Cohen R; Department of Gynaecology and Medical Genetics Institute, Hebrew University Faculty of Medicine, Shaare Zedek Medical Centre, Jerusalem, Israel., Bober SL; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., da Silva Filho AL; Departamento de Ginecologia e Obstetricia da UFMG, Federal University of Minas Gerais, Belo Horizonte, Brazil., Johansen N; Department of Gynaecology and Obstetrics, Sørlandet Hospital HF Arendal, Arendal, Norway., Guidozzi F; Deparment of Obstetrics and Gynaecology, University of Witwatersrand, Johanesburg, South Africa., Evans DG; University of Manchester, Prevent Breast Cancer Centre, Manchester, UK., Menon U; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Kingsberg SA; University Hospitals Cleveland Medical Center, Case Western University School of Medicine, Cleveland, Ohio, USA., Powell CB; Kaiser Permanente Northern California, Hereditary Cancer Program, San Francisco, California, USA., Grandi G; Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy., Marchetti C; Department of Women's and Children's Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Catholic University Sacred Heart, Rome, Italy., Jacobson M; Women's College Hospital and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Brennan DJ; UCD Gynaecological Oncology Group, UCD School of Medicine, Mater University Hospital, Dublin, Ireland., Hickey M; Department of Obstetrics and Gynaecology, Research Precinct, Level 7, The Royal Women's Hospital, University of Melbourne, Parkville, Victoria, Australia.

Publikováno v: BJOG : an international journal of obstetrics and gynaecology [BJOG] 2023 Nov; Vol. 130 (12), pp. 1437-1450. Date of Electronic Publication: 2023 May 02.

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors.

Autor: van Bommel MHD; Department of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. Majke.vanBommel@radboudumc.nl., Steenbeek MP; Department of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., IntHout J; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Hermens RPMG; Scientific Institute for Quality of Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Hoogerbrugge N; Department of Human Genetics, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Harmsen MG; Department of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van Doorn HC; Department of Gynaecology, Erasmus MC Cancer Clinic, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands., Mourits MJE; Department of Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., van Beurden M; Center for Gynaecological Oncology Amsterdam (CGOA), Netherlands Cancer Institute/Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Zweemer RP; Department of Gynaecological Oncology, UMC Utrecht Cancer Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Gaarenstroom KN; Department of Obstetrics and Gynaecology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Slangen BFM; Department of Obstetrics and Gynaecology, Maastricht University Medical Center, GROW-School for Oncology and Developmental Biology, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands., Brood-van Zanten MMA; Center for Gynaecological Oncology Amsterdam (CGOA), Netherlands Cancer Institute/Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Center for Gynaecological Oncology Amsterdam (CGOA), AmsterdamUMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Vos MC; Gynaecologic Oncologic Center South Location Elisabeth-TweeSteden Hospital, Hilvarenbeekseweg 60, 5000 LC, Tilburg, The Netherlands., Piek JM; Gynaecologic Oncologic Center South Location Catharina Hospital, Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands., van Lonkhuijzen LRCW; Center for Gynaecological Oncology Amsterdam (CGOA), AmsterdamUMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Apperloo MJA; Department of Obstetrics and Gynaecology, Medical Center Leeuwarden, Henri Dunantweg 2, 8934 AD, Leeuwarden, The Netherlands., Coppus SFPJ; Department of Obstetrics and Gynaecology, Maxima Medical Center, De Run 4600, 5504 DB, Veldhoven, The Netherlands., Prins JB; Department of Medical Psychology, Radboud Institute F Or Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Custers JAE; Department of Medical Psychology, Radboud Institute F Or Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Hullu JA; Department of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Apr; Vol. 30 (4), pp. 3409-3418. Date of Electronic Publication: 2022 Jan 08.